Journal article
An ACE therapy for COVID-19
Science translational medicine, v 12(541)
29 Apr 2020
Abstract
Recombinant human soluble ACE2 inhibits SARS-CoV-2 viral infection in human organoids in vitro.
Recombinant human soluble ACE2 inhibits SARS-CoV-2 viral infection in human organoids in vitro.
Metrics
4 Record Views
Details
- Title
- An ACE therapy for COVID-19
- Creators
- Christopher B. Rodell - School of Biomedical Engineering, Health and Science Systems, Philadelphia, PA 19104, USA. Email: cbr58@drexel.edu
- Publication Details
- Science translational medicine, v 12(541)
- Publisher
- American Association for the Advancement of Science (AAAS)
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- School of Biomedical Engineering, Science, and Health Systems
- Other Identifier
- 991019341846904721